As clinical trials grow increasingly complex and multi-modal, the pharmaceutical industry is pivoting toward AI-driven agentic orchestrators and lakehouse architectures to untangle disparate data ...

As threat actors operationalize AI to accelerate attacks, they are also leveraging the wider global interest around AI itself as a social engineering lure. In recent months, Microsoft Threat ...